Overview


According to FutureWise analysis the market for vial adaptors for reconstitution drug in 2023 is US$ 1.09 billion, and is expected to reach US$ 1.92 billion by 2031 at a CAGR of 7.3%.

The vial adapter is a sterile, non-invasive, single-use medical device used to transfer and combine medications found in vials. A plastic spike that is a part of the vial adapter and is positioned in the middle of the device is used to puncture the elastomeric closure of a vial. The most affordable method for quickly and safely transferring and reconstituting medications between vials and syringes is to use a vial adaptor. The end-user variability associated with conventional needle aspirations is significantly reduced by the use of vial adapter spike technology, which offers a consistent designed depth for medication and diluent aspiration. Hence, the most effective and economical vial overfill quantities for pharmaceutical products can be guaranteed.

Since these vial adaptors are now the safest options for quick medication transfer between vials, there has been a steady growth in demand for them on the global market for reconstitution pharmaceuticals. Because of their remarkable cost-effectiveness and lower risk of needlestick injuries, these vial adaptors are generally predicted to witness a fast surge in demand. There is a demand for vial adaptors for reconstitution drugs because of the prevalence of infectious diseases, the aging population, and elevated safety concerns.

One of the key reasons propelling the market for vial adaptors for reconstitution medicine growth is the increased prevalence of chronic diseases. Chronic disease patients are becoming more prevalent in industrialised nations including the United States, Canada, the United Kingdom, Australia, France, Germany, and others. This is because people's diet and living patterns have changed in these nations. Here is an increase in demand for vial adaptors for reconstitution drugs as chronic illnesses have become more prevalent. The lack of competent labour is one of the problems preventing the vial adaptors for reconstitution medicine sector from expanding.

The employment of such technologies by an inexperienced workforce has increased the incidence of wrong result interpretations and numerous observations made during testing and research due to a dearth of educated laboratory employees. As a result, the growth of the industry is hampered by problems such as a lack of experienced employees and report errors. Due to fluctuating prices for the raw materials used to create them, the market for vial adaptors, which are used in reconstitution medicine, is expanding. Premium polymers are used in the production of vial adaptors. To find the raw materials, reputable sellers rely on forming alliances with suppliers. Vendors are able to maintain uniform raw material prices and low supply costs as a result. Yet, the cost of these polymers might vary significantly because the price of crude oil swings so much on a daily basis. The price of polymers is directly influenced by the price of crude oil. This makes it difficult for vendors to select the best procurement strategies to find raw materials at the best prices. These occurrences are expected to cause the market to grow throughout the course of the projected year.

FutureWise Market Research has published a report that provides an insightful analysis of global vial adaptors for reconstitution drug market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the global vial adaptors for reconstitution drug market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Baxter International Inc.
  • Becton, Dickinson and Company 
  • Cardinal Health, Inc. 
  • Sensile Medical AG 
  • Unilife Corporation 
  • West Pharmaceutical Services, Inc.
  • Miltenyi Biotec
  • Randox Laboratories Ltd.
  • Sartorious AG
  • Thermo Fisher Scientific
  • Agilent Technologies
  • B. Braun Medical Inc.
  • MedXL Inc.
  • Helapet
  • Nipro Pharma Packaging India

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • 13mm Vial Adaptor
  • 20mm Vial Adaptor

By Material

  • Polycarbonate
  • Silicon
  • Polyethylene Teraphthalate Glycol
  • Polyethylene
  • Others

By Therapeutic Area

  • Autoimmune Diseases
  • Infectious Diseases
  • Metabolic Conditions
  • Reproductive Health
  • Others

By Delivery Mode

  • Injection
  • Infusion

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. A few of the major factors responsible for its significant market share include the existence of key players, a well-established healthcare infrastructure, and the accessibility of branded drugs. In addition, favourable government initiatives and a rise in research partnership numbers are among the factors anticipated to spur market expansion. The United States has a unique healthcare system among the developed countries. The primary cause of the market's expansion in the nation is the rising incidence of chronic diseases region. Additionally, based on therapeutic areas, infectious diseases hold a market share of 42.2% in 2022 globally.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Global Vial Adaptors for Reconstitution Drug Market By Product Type, By Material, By Therapeutic Area, By Delivery Mode, and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Vial Adaptors for Reconstitution Drug Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Vial Adaptors for Reconstitution Drug Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Vial Adaptors for Reconstitution Drug Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Vial Adaptors for Reconstitution Drug Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 13mm Vial Adaptor
        2. 20mm Vial Adaptor

  • 8.   Vial Adaptors for Reconstitution Drug Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Polycarbonate
        2. Silicon
        3. Polyethylene Teraphthalate Glycol
        4. Polyethylene
        5. Others

  • 9.   Vial Adaptors for Reconstitution Drug Market, By Therapeutic Area Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Autoimmune Diseases
        2. Infectious Diseases
        3. Metabolic Conditions
        4. Reproductive Health
        5. Others

  • 10.   Vial Adaptors for Reconstitution Drug Market, By Delivery Mode Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Injection
        2. Infusion

  • 11.   North America Vial Adaptors for Reconstitution Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Vial Adaptors for Reconstitution Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Vial Adaptors for Reconstitution Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Vial Adaptors for Reconstitution Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Baxter International Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Becton, Dickinson and Company
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cardinal Health, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Sensile Medical AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Unilife Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. West Pharmaceutical Services, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Miltenyi Biotec
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Randox Laboratories Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sartorious AG
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Thermo Fisher Scientific
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Agilent Technologies
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.B. Braun Medical Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. MedXL Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Helapet
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Nipro Pharma Packaging India
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients